These secondary benefits can be especially valuable for patients who are overweight or obese and already dealing with hypertension, dyslipidemia, or other cardiac risk factors
The most common are mild nausea, bloating, or digestive changes, especially in the early stages
The SUMMIT trial recently evaluated the effect of tirzepatide, another GLP-1 RA, in people with obesity related HfpEF and found treatment with tirzepatide to be associated with a lower risk of composite death from cardiovascular causes or worsening heart failure in patients with HFpEF and obesity, compared to placebo, suggesting tirzepatide use may be on the horizon for the co-management of MASLD and HFpEF 80
And what does each dose feel like
Tirzepatide Injection In Clinic $255.00 IN STOCK Included with Purchase: 1 month supply of Tirzepatide Injection w/ Glycine and B12 (2.5mg-15mg) (4 Injections) (Dosage varies from 2.5mg to 15mg and is dependent on the Month ordered) Telehealth Consult with our Physician